(Q37332989)

19 August 2017

Performance characteristics of plasma amyloid-beta 40 and 42 assays (English)

1 reference

19 August 2017

6

Anne M Fagan

1 reference

19 August 2017

8

Bradley T Hyman

1 reference

19 August 2017

9

Dennis J Selkoe

1 reference

19 August 2017

1

Olivia I Okereke

1 reference

19 August 2017

10

Francine Grodstein

1 reference

19 August 2017

Weiming Xia

2

1 reference

19 August 2017

Michael C Irizarry

3

1 reference

19 August 2017

Xiaoyan Sun

4

1 reference

19 August 2017

Wei Q Qiu

5

1 reference

19 August 2017

Pankaj D Mehta

7

1 reference

19 August 2017

1 January 2009

1 reference

Journal of Alzheimer's Disease

19 August 2017

1 reference

19 August 2017

16

1 reference

19 August 2017

2

1 reference

19 August 2017

277-285

1 reference

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Clearance of amyloid-beta by circulating lipoprotein receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Biomarkers of Alzheimer disease in plasma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Laboratory issues: use of nutritional biomarkers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737811

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19221417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19221417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3233/JAD-2009-0948

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19221417

1 reference